Zhitong Finance App News, Goli Pharmaceutical-B (01672.HK) announced that two posters of its obesity pipeline oral small molecule GIPR agonist ASC48 and GLP-1R/GIPR/GCGR three-target agonist peptide ASC37 will be displayed at ObesityWeek (ObesityWeek®) 2026. The conference will be held from November 14 to 17, 2026 in Washington, DC, USA.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.